glp 1 receptor agonists beyond their pancreatic effects The and extrapancreatic effect of GLP-1. GLP-1, glucagon Current Insights, Advantages and Challenges
Description
10.1111/dom.12506

J Clin Endocrinol Metab 103(1):288294

Glucose stimulated insulin release was assessed in the presence of indicated concentrations of glucose and incretin receptor agonists for 30 min and the supernatant was collected, centrifuged, and processed for the ELISA as per the manufacturers protocol

111091, Aug

(2021) 106:e1420e32
(2014) 306:E143141
